Peglion JL - Search Results

1

Ca2+ channel inhibition by a new dihydropyridine derivative, S11568, and its enantiomers S12967 and S12968.

Randle JC, Lombet A, Nagel N, Abraham C, Aptel H, Peglion JL, Renaud JF. Randle JC, et al. Among authors: peglion jl. Eur J Pharmacol. 1990 Nov 6;190(1-2):85-96. doi: 10.1016/0014-2999(90)94115-e. Eur J Pharmacol. 1990. PMID: 1706275

2

Inhibition of L-type but not T-type calcium channel current by a new dihydropyridine derivative, S11568.

Randle JC, Péglion JL, Renaud JF. Randle JC, et al. Among authors: peglion jl. J Cardiovasc Pharmacol. 1991 Feb;17(2):348-50. doi: 10.1097/00005344-199102000-00024. J Cardiovasc Pharmacol. 1991. PMID: 1709243

3

Ca2+ channel inhibition in a rat osteoblast-like cell line, UMR 106, by a new dihydropyridine derivative, S11568.

Morain P, Peglion JL, Giesen-Crouse E. Morain P, et al. Among authors: peglion jl. Eur J Pharmacol. 1992 Sep 10;220(1):11-7. doi: 10.1016/0014-2999(92)90005-o. Eur J Pharmacol. 1992. PMID: 1385178

4

In vivo reversal of multidrug resistance by two new dihydropyridine derivatives, S16317 and S16324.

Kraus-Berthier L, Guilbaud N, Peglion JL, Leonce S, Lombet A, Pierre A, Atassi G. Kraus-Berthier L, et al. Among authors: peglion jl. Acta Oncol. 1994;33(6):631-7. doi: 10.3109/02841869409121774. Acta Oncol. 1994. PMID: 7946440

5

The calcium channel antagonist S 11568 causes endothelium-dependent relaxation in canine arteries.

Vilaine JP, Biondi ML, Villeneuve N, Feletou M, Peglion JL, Vanhoutte PM. Vilaine JP, et al. Among authors: peglion jl. Eur J Pharmacol. 1991 May 2;197(1):41-8. doi: 10.1016/0014-2999(91)90362-t. Eur J Pharmacol. 1991. PMID: 1654260

6

Sigma ligand S14905 and locomotor activity in mice.

Hascoet M, Bourin M, Payeur R, Lombet A, Peglion JL. Hascoet M, et al. Among authors: peglion jl. Eur Neuropsychopharmacol. 1995 Dec;5(4):481-9. doi: 10.1016/0924-977x(95)00034-m. Eur Neuropsychopharmacol. 1995. PMID: 8998401

7

Stereospecific in vitro and in vivo effects of the new sinus node inhibitor (+)-S 16257.

Thollon C, Bidouard JP, Cambarrat C, Lesage L, Reure H, Delescluse I, Vian J, Peglion JL, Vilaine JP. Thollon C, et al. Among authors: peglion jl. Eur J Pharmacol. 1997 Nov 19;339(1):43-51. doi: 10.1016/s0014-2999(97)01364-2. Eur J Pharmacol. 1997. PMID: 9450615

8

Multidrug-resistance circumvention and inhibition of [h-3] azidopine photolabeling of p-glycoprotein by new dihydropyridine derivatives displaying a low-affinity for calcium channels.

Leonce S, Pierre A, Perez V, Guilbaud N, Krausberthier L, Genton A, Lombet A, Peglion J, Atassi G. Leonce S, et al. Int J Oncol. 1994 Jun;4(6):1243-50. doi: 10.3892/ijo.4.6.1243. Int J Oncol. 1994. PMID: 21567044

9

S 15535: a highly selective benzodioxopiperazine 5-HT1A receptor ligand which acts as an agonist and an antagonist at presynaptic and postsynaptic sites respectively.

Millan MJ, Rivet JM, Canton H, Lejeune F, Gobert A, Widdowson P, Bervoets K, Brocco M, Peglion JL. Millan MJ, et al. Among authors: peglion jl. Eur J Pharmacol. 1993 Jan 5;230(1):99-102. doi: 10.1016/0014-2999(93)90416-f. Eur J Pharmacol. 1993. PMID: 8381359

10

Modulation of mesolimbic dopamine release by the selective dopamine D3 receptor antagonist, (+)-S 14297.

Rivet JM, Audinot V, Gobert A, Peglion JL, Millan MJ. Rivet JM, et al. Among authors: peglion jl. Eur J Pharmacol. 1994 Nov 24;265(3):175-7. doi: 10.1016/0014-2999(94)90429-4. Eur J Pharmacol. 1994. PMID: 7875234

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters